AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Crohn Disease (CD)

Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962Phase 1, Phase 213 sites๐Ÿ“ Scottsdale๐Ÿ“ Sacramento๐Ÿ“ San Francisco Tr1X, Inc. ยท Tests: TRX103, Cyclophosphamide Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study NCT06896305NA1 site๐Ÿ“ Milan IRCCS Ospedale San Raffaele ยท Tests: CDED (Crohn's Disease Exclusion Diet) in addition to anti-TNF therapy, Anti-TNF Therapy Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease NCT07078994Phase 220 sites๐Ÿ“ Barnaul๐Ÿ“ Ufa๐Ÿ“ Moscow Biocad ยท Tests: anti-TL1A monoclonal antibody, low dose, anti-TL1A monoclonal antibody, medium dose, anti-TL1A monoclonal antibody, higโ€ฆ HB-adMSCs for the Treatment of Crohn's Disease NCT07077746Phase 21 site๐Ÿ“ Sugar Land Hope Biosciences Research Foundation ยท Tests: HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells, 0.9% sodium chloride TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1) NCT05903066n/a18 sites๐Ÿ“ Liรจge๐Ÿ“ Amiens๐Ÿ“ Bordeaux Groupe d'Etude Therapeutique des Affections Inflammatoires โ€ฆ ยท Tests: Magnetic Resonance Enterography (MRE) Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD NCT06997965Phase 48 sites๐Ÿ“ Miami๐Ÿ“ Orlando๐Ÿ“ Chicago Alimentiv Inc. ยท Tests: Mirikizumab Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease NCT06976853Phase 23 sites๐Ÿ“ Beverly Hills๐Ÿ“ St Louis๐Ÿ“ New York Washington University School of Medicine ยท Tests: Tirzepatide, Standard of care treatment Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease NCT06925061Phase 212 sites๐Ÿ“ Clermont-Ferrand๐Ÿ“ Crรฉteil๐Ÿ“ Le Kremlin-Bicรชtre Madeleine Bezault ยท Tests: After surgery for Crohn's disease, eligible patients will be randomized 1:1 to receive oral EXL01 or placebo with โ€ฆ A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Crohn Disease on Advanced Therapies NCT06890637NA6 sites๐Ÿ“ Kochi๐Ÿ“ Mumbai๐Ÿ“ New Delhi All India Institute of Medical Sciences ยท Tests: Fecal Microbial Transplantation, Crohns Disease Exclusion Diet, Sham transplantation, Sham Diet, Advanced therapy Leucine-rich ฮฑ2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context NCT07621783n/a1 site๐Ÿ“ Bonheiden Imelda GI Clinical Research Center ยท Tests: Leucine-rich ฮฑ2-glycoprotein Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD NCT06064864NA1 site๐Ÿ“ Seoul Asan Medical Center ยท Tests: Infliximab-Dyyb Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial NCT06216899NA3 sites๐Ÿ“ Philadelphia๐Ÿ“ Seattle๐Ÿ“ Halifax Seattle Children's Hospital ยท Tests: Whole-food based smoothie, Formula Comparison Between Artificial Intelligence and Standard Reading to Investigate Suspected Crohn Disease: the SCAI STUDY NCT07111715n/a1 site๐Ÿ“ Brescia Fondazione Poliambulanza Istituto Ospedaliero ยท Tests: Small bowel Video Capsule Endoscopy (VCE) using an Capsule System equipped with a Deep Neural Network based system callโ€ฆ Impact of Advanced Crohn's Disease Therapies on Sleep Quality NCT07649408n/a1 site๐Ÿ“ Tel Aviv Shmuel Kivity, MD ยท Tests: Wearable activity and sleep tracker Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease NCT07644117n/a1 site๐Ÿ“ Tel Aviv Shmuel Kivity, MD ยท Tests: This is an observational study with no intervention. Patients will receive anti- TNF therapy as part of their standard โ€ฆ Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives NCT07316621n/a10 sites๐Ÿ“ Roma๐Ÿ“ Amsterdam๐Ÿ“ Groningen GLSMED Learning Health S.A. Value of IUS in Predicting Vedolizumab Efficacy and Assessing Transmural Healing in Early Crohn's Disease: A Multicenter, Prospective Study NCT07093294n/a1 site๐Ÿ“ Changsha The Third Xiangya Hospital of Central South University A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease NCT06226883Phase 2225 sites๐Ÿ“ Lancaster๐Ÿ“ San Diego๐Ÿ“ Colorado Springs Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eliโ€ฆ ยท Tests: Placebo, MORF-057 Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease NCT07292012Phase 46 sites๐Ÿ“ Brest๐Ÿ“ Clermont-Ferrand๐Ÿ“ Nรฎmes Groupe d'Etude Therapeutique des Affections Inflammatoires โ€ฆ ยท Tests: Mirikizumab - IV, Mirikizumab - SC Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease NCT07629245Phase 1, Phase 21 site๐Ÿ“ Marseille Assistance Publique Hopitaux De Marseille ยท Tests: injection of thawed SVF Specific Dietary Pattern for Crohn's Disease Patients Following Surgery NCT05502965NA1 site๐Ÿ“ Hangzhou Second Affiliated Hospital, Zhejiang University, School of โ€ฆ ยท Tests: dietary pattern, EEN WAter Preparation in Crohn's Disease's Imagery NCT06690632NA1 site๐Ÿ“ Toulouse University Hospital, Toulouse ยท Tests: water preparation, polyethylene glycol preparation Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease NCT06606808Phase 1, Phase 21 site๐Ÿ“ Groningen University Medical Center Groningen ยท Tests: Risankizumab-800CW 4.5 mg, Risankizumab-800CW 15 mg, Risankizumab-800CW 25 mg, Risankizumab-800CW optimal dose Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics NCT07261826n/a1 site๐Ÿ“ Shanghai Chen QiYi DB-3Q for the Treatment of Medically Refractory Crohn's Disease NCT07625293Phase 21 site๐Ÿ“ St Louis Direct Biologics, LLC ยท Tests: DB-3Q, Placebo A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) NCT06764615Phase 216 sites๐Ÿ“ Glen Burnie๐Ÿ“ Tyler๐Ÿ“ Chongqing Takeda ยท Tests: Zasocitinib Hybrid Endoscopic Stricturotomy Plus Balloon Dilation Versus Stricturotomy Alone for Short Crohn's Disease Strictures NCT06958159NA1 site๐Ÿ“ Hyderabad Asian Institute of Gastroenterology, India ยท Tests: Endoscopic Stricturotomy, Endoscopic Balloon Dilation A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease NCT07113522Phase 266 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Sun City Mirador Therapeutics, Inc. ยท Tests: MT-501, MT-201 Evaluation of the SMART IBD App in Pediatric IBD NCT07195123NA1 site๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: SMART-IBD Surgery vs Biologics for Treating Stricturing CD--a RCT NCT05421455NA1 site๐Ÿ“ Nanjing Zhu Weiming ยท Tests: Group A, Group B
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy